nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.116	1	CbGbCtD
Carfilzomib—PSMB10—heart—Kawasaki disease	0.0432	0.113	CbGeAlD
Carfilzomib—PSMB5—cardiac ventricle—Kawasaki disease	0.0375	0.0983	CbGeAlD
Carfilzomib—PSMB5—myocardium—Kawasaki disease	0.0353	0.0924	CbGeAlD
Carfilzomib—PSMB1—cardiac ventricle—Kawasaki disease	0.0328	0.0859	CbGeAlD
Carfilzomib—PSMB2—cardiac ventricle—Kawasaki disease	0.032	0.0838	CbGeAlD
Carfilzomib—PSMB1—myocardium—Kawasaki disease	0.0308	0.0808	CbGeAlD
Carfilzomib—PSMB2—myocardium—Kawasaki disease	0.0301	0.0788	CbGeAlD
Carfilzomib—PSMB8—heart—Kawasaki disease	0.0279	0.073	CbGeAlD
Carfilzomib—PSMB5—heart—Kawasaki disease	0.0246	0.0645	CbGeAlD
Carfilzomib—PSMB1—heart—Kawasaki disease	0.0215	0.0564	CbGeAlD
Carfilzomib—PSMB1—skin of body—Kawasaki disease	0.0211	0.0552	CbGeAlD
Carfilzomib—PSMB2—heart—Kawasaki disease	0.021	0.055	CbGeAlD
Carfilzomib—PSMB2—skin of body—Kawasaki disease	0.0206	0.0539	CbGeAlD
Carfilzomib—PSMB10—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.0132	0.0262	CbGpPWpGaD
Carfilzomib—PSMB9—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.0131	0.026	CbGpPWpGaD
Carfilzomib—PSMB10—Mitotic Anaphase—CENPU—Kawasaki disease	0.0125	0.0248	CbGpPWpGaD
Carfilzomib—PSMB10—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.0124	0.0247	CbGpPWpGaD
Carfilzomib—PSMB9—Mitotic Anaphase—CENPU—Kawasaki disease	0.0124	0.0247	CbGpPWpGaD
Carfilzomib—PSMB9—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.0124	0.0246	CbGpPWpGaD
Carfilzomib—PSMB5—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00997	0.0198	CbGpPWpGaD
Carfilzomib—PSMB1—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00997	0.0198	CbGpPWpGaD
Carfilzomib—PSMB2—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00997	0.0198	CbGpPWpGaD
Carfilzomib—PSMB8—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00983	0.0195	CbGpPWpGaD
Carfilzomib—PSMB1—Mitotic Anaphase—CENPU—Kawasaki disease	0.00945	0.0188	CbGpPWpGaD
Carfilzomib—PSMB2—Mitotic Anaphase—CENPU—Kawasaki disease	0.00945	0.0188	CbGpPWpGaD
Carfilzomib—PSMB5—Mitotic Anaphase—CENPU—Kawasaki disease	0.00945	0.0188	CbGpPWpGaD
Carfilzomib—PSMB1—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00941	0.0187	CbGpPWpGaD
Carfilzomib—PSMB2—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00941	0.0187	CbGpPWpGaD
Carfilzomib—PSMB5—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00941	0.0187	CbGpPWpGaD
Carfilzomib—PSMB8—Mitotic Anaphase—CENPU—Kawasaki disease	0.00932	0.0185	CbGpPWpGaD
Carfilzomib—PSMB8—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00928	0.0184	CbGpPWpGaD
Carfilzomib—PSMB10—M Phase—CENPU—Kawasaki disease	0.00806	0.016	CbGpPWpGaD
Carfilzomib—PSMB9—M Phase—CENPU—Kawasaki disease	0.00802	0.016	CbGpPWpGaD
Carfilzomib—PSMB10—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00739	0.0147	CbGpPWpGaD
Carfilzomib—PSMB9—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00735	0.0146	CbGpPWpGaD
Carfilzomib—PSMB5—M Phase—CENPU—Kawasaki disease	0.00611	0.0122	CbGpPWpGaD
Carfilzomib—PSMB1—M Phase—CENPU—Kawasaki disease	0.00611	0.0122	CbGpPWpGaD
Carfilzomib—PSMB2—M Phase—CENPU—Kawasaki disease	0.00611	0.0122	CbGpPWpGaD
Carfilzomib—PSMB10—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.00603	0.012	CbGpPWpGaD
Carfilzomib—PSMB8—M Phase—CENPU—Kawasaki disease	0.00602	0.012	CbGpPWpGaD
Carfilzomib—PSMB9—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.006	0.0119	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—BLK—Kawasaki disease	0.00561	0.0112	CbGpPWpGaD
Carfilzomib—PSMB2—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.0056	0.0111	CbGpPWpGaD
Carfilzomib—PSMB5—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.0056	0.0111	CbGpPWpGaD
Carfilzomib—PSMB1—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.0056	0.0111	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—BLK—Kawasaki disease	0.00558	0.0111	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00553	0.011	CbGpPWpGaD
Carfilzomib—PSMB8—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00552	0.011	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.0055	0.0109	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—CENPU—Kawasaki disease	0.00494	0.00983	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—CENPU—Kawasaki disease	0.00492	0.00978	CbGpPWpGaD
Carfilzomib—PSMB2—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.00457	0.00909	CbGpPWpGaD
Carfilzomib—PSMB1—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.00457	0.00909	CbGpPWpGaD
Carfilzomib—PSMB5—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.00457	0.00909	CbGpPWpGaD
Carfilzomib—PSMB8—Vpu mediated degradation of CD4—CD4—Kawasaki disease	0.0045	0.00896	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—BLK—Kawasaki disease	0.00425	0.00846	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—BLK—Kawasaki disease	0.00425	0.00846	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—BLK—Kawasaki disease	0.00425	0.00846	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—BLK—Kawasaki disease	0.00419	0.00834	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00419	0.00833	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00419	0.00833	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00419	0.00833	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00413	0.00821	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—CENPU—Kawasaki disease	0.00375	0.00745	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—CENPU—Kawasaki disease	0.00375	0.00745	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—CENPU—Kawasaki disease	0.00375	0.00745	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—CENPU—Kawasaki disease	0.00369	0.00734	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ITPKC—Kawasaki disease	0.00329	0.00655	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ITPKC—Kawasaki disease	0.00328	0.00652	CbGpPWpGaD
Carfilzomib—ABCB1—heart—Kawasaki disease	0.00321	0.00841	CbGeAlD
Carfilzomib—PSMB10—HIV Infection—CCR5—Kawasaki disease	0.00298	0.00592	CbGpPWpGaD
Carfilzomib—PSMB9—HIV Infection—CCR5—Kawasaki disease	0.00296	0.00589	CbGpPWpGaD
Carfilzomib—PSMB10—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00288	0.00572	CbGpPWpGaD
Carfilzomib—PSMB9—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00286	0.0057	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ITPKC—Kawasaki disease	0.0025	0.00497	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ITPKC—Kawasaki disease	0.0025	0.00497	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ITPKC—Kawasaki disease	0.0025	0.00497	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ITPKC—Kawasaki disease	0.00246	0.0049	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—BLK—Kawasaki disease	0.00226	0.0045	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CCR5—Kawasaki disease	0.00226	0.00449	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CCR5—Kawasaki disease	0.00226	0.00449	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—CCR5—Kawasaki disease	0.00226	0.00449	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—BLK—Kawasaki disease	0.00225	0.00448	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CCR5—Kawasaki disease	0.00223	0.00442	CbGpPWpGaD
Carfilzomib—PSMB1—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00218	0.00434	CbGpPWpGaD
Carfilzomib—PSMB2—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00218	0.00434	CbGpPWpGaD
Carfilzomib—PSMB5—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00218	0.00434	CbGpPWpGaD
Carfilzomib—PSMB8—Host Interactions of HIV factors—CD4—Kawasaki disease	0.00215	0.00428	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.00214	0.00426	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD40—Kawasaki disease	0.00188	0.00374	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD40—Kawasaki disease	0.00187	0.00372	CbGpPWpGaD
Carfilzomib—PSMB10—HIV Infection—CD4—Kawasaki disease	0.00187	0.00372	CbGpPWpGaD
Carfilzomib—PSMB9—HIV Infection—CD4—Kawasaki disease	0.00186	0.0037	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—BLK—Kawasaki disease	0.00171	0.00341	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—BLK—Kawasaki disease	0.00171	0.00341	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—BLK—Kawasaki disease	0.00171	0.00341	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—BLK—Kawasaki disease	0.00169	0.00336	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.00164	0.00326	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD40—Kawasaki disease	0.00142	0.00283	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD40—Kawasaki disease	0.00142	0.00283	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD40—Kawasaki disease	0.00142	0.00283	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—CD4—Kawasaki disease	0.00142	0.00282	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CD4—Kawasaki disease	0.00142	0.00282	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CD4—Kawasaki disease	0.00142	0.00282	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FCGR2A—Kawasaki disease	0.00141	0.00281	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FCGR2A—Kawasaki disease	0.00141	0.0028	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD40—Kawasaki disease	0.0014	0.00279	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CD4—Kawasaki disease	0.0014	0.00278	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—BLK—Kawasaki disease	0.00137	0.00273	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—BLK—Kawasaki disease	0.00137	0.00272	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD40—Kawasaki disease	0.00114	0.00227	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD40—Kawasaki disease	0.00113	0.00226	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FCGR2A—Kawasaki disease	0.00107	0.00213	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FCGR2A—Kawasaki disease	0.00107	0.00213	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FCGR2A—Kawasaki disease	0.00107	0.00213	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FCGR2A—Kawasaki disease	0.00106	0.0021	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BLK—Kawasaki disease	0.00104	0.00207	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BLK—Kawasaki disease	0.00104	0.00207	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BLK—Kawasaki disease	0.00104	0.00207	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BLK—Kawasaki disease	0.00103	0.00204	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD40—Kawasaki disease	0.000864	0.00172	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD40—Kawasaki disease	0.000864	0.00172	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD40—Kawasaki disease	0.000864	0.00172	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40—Kawasaki disease	0.000852	0.00169	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000842	0.00167	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—Kawasaki disease	0.000818	0.00163	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—Kawasaki disease	0.000814	0.00162	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CRP—Kawasaki disease	0.000735	0.00146	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ITPKC—Kawasaki disease	0.000735	0.00146	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CRP—Kawasaki disease	0.000731	0.00145	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CCR5—Kawasaki disease	0.00073	0.00145	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	0.000729	0.00145	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CCR5—Kawasaki disease	0.000726	0.00144	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—Kawasaki disease	0.00062	0.00123	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—Kawasaki disease	0.00062	0.00123	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—Kawasaki disease	0.00062	0.00123	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—Kawasaki disease	0.000611	0.00122	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CRP—Kawasaki disease	0.000557	0.00111	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CRP—Kawasaki disease	0.000557	0.00111	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CRP—Kawasaki disease	0.000557	0.00111	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CCR5—Kawasaki disease	0.000553	0.0011	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CCR5—Kawasaki disease	0.000553	0.0011	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CCR5—Kawasaki disease	0.000553	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CRP—Kawasaki disease	0.000549	0.00109	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CCR5—Kawasaki disease	0.000545	0.00108	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCR5—Kawasaki disease	0.000511	0.00102	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCR5—Kawasaki disease	0.000509	0.00101	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—Kawasaki disease	0.000496	0.000987	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—Kawasaki disease	0.000494	0.000982	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—Kawasaki disease	0.000458	0.000911	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—Kawasaki disease	0.000456	0.000907	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—Kawasaki disease	0.000387	0.00077	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—Kawasaki disease	0.000387	0.00077	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—Kawasaki disease	0.000387	0.00077	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—Kawasaki disease	0.000382	0.000759	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—Kawasaki disease	0.000376	0.000748	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—Kawasaki disease	0.000376	0.000748	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—Kawasaki disease	0.000376	0.000748	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—Kawasaki disease	0.000371	0.000737	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.00036	0.000715	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—Kawasaki disease	0.000347	0.000691	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—Kawasaki disease	0.000347	0.000691	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—Kawasaki disease	0.000347	0.000691	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—Kawasaki disease	0.000342	0.000681	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—Kawasaki disease	0.000279	0.000556	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—Kawasaki disease	0.000278	0.000553	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—VEGFA—Kawasaki disease	0.000251	0.000499	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—VEGFA—Kawasaki disease	0.00025	0.000497	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—Kawasaki disease	0.000212	0.000421	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—Kawasaki disease	0.000212	0.000421	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—Kawasaki disease	0.000212	0.000421	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—Kawasaki disease	0.000209	0.000415	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—VEGFA—Kawasaki disease	0.00019	0.000378	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—VEGFA—Kawasaki disease	0.00019	0.000378	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—VEGFA—Kawasaki disease	0.00019	0.000378	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—VEGFA—Kawasaki disease	0.000187	0.000373	CbGpPWpGaD
